Kalytera Therapeutics Inc.

(SMQ.H:CA)

By |

Profile

Kalytera Therapeutics Inc develops cannabinoid (CBD) therapeutics for a range of unmet medical needs. CBD is a compound that shows activity against various pharmacological targets. The company develops CBD formulations and prodrugs to target specific disease sites within the body. Its programs include Bone Fracture Healing Program, Osteogenesis Imperfecta Program, Osteoporosis Program, and Osteoporosis in Prader-Willi syndrome.

Contact Information

Website: www.kalytera.co
Email: lisa-marie@delavaco.com
Main Phone: +1 415 218-3900
Address: 41 Thunderbird Drive
Address 2: Suite 204
State: CA
City / Town: Novato
Country: USA
Postal Code: 94949

Issuer Information

Exchange: CDX
CEO: Robert E. Farrell
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Kalytera Therapeutics Inc develops cannabinoid (CBD) therapeutics for a range of unmet medical needs. CBD is a compound that shows activity against various pharmacological targets. The company develops CBD formulations and prodrugs to target specific disease sites within the body. Its programs include Bone Fracture Healing Program, Osteogenesis Imperfecta Program, Osteoporosis Program, and Osteoporosis in Prader-Willi syndrome.

Contact Information

Website: www.kalytera.co
Email: lisa-marie@delavaco.com
Main Phone: +1 415 218-3900
Address: 41 Thunderbird Drive
Address 2: Suite 204
State: CA
City / Town: Novato
Country: USA
Postal Code: 94949

Issuer Information

Exchange: CDX
CEO: Robert E. Farrell
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 281,085,328.00 EPS (TTM) -0.26 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 0.3 0.3 0.3 0.3
Low Target Price Estimate 0.3 0.3 0.3 0.3
Mean Target Price Estimate 0.3 0.3 0.3 0.3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/08/11 08/08/11 08/08/11 08/08/11
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1